483
Eli Lilly and CompanyEli Lilly and Company – FDA 483, Nov 26, 2024
Record Details
An FDA inspection of Eli Lilly and Company in Concord, NC, revealed an issue with equipment design related to drug product storage. Specifically, the firm's temperature mapping verification for semi-finished syringes was found to be inadequate because the load pattern simulation did not accurately represent a full load. This indicates a deficiency in ensuring appropriate storage conditions for drug products.
View Company Profile
ID · 7d8c5b19-5820-4d6d-bf4a-be654f05b00e
Other documents for Eli Lilly and Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.